Tag:
VaxGen
Latest Headlines
Latest Headlines
VaxGen story goes beyond manufacturing
Though not a manufacturing issue per se, Congressional lobbying is one of its great influencers. Our mention last week of VaxGen's experience in the mid-2000s--in which government funds for an
VaxGen sells anthrax vaccine to its old rival
Reduced to a skeleton crew and a bleak outlook, South San Francisco-based VaxGen sold its experimental anthrax vaccine to its former chief rival, Emergent BioSolutions, for $2 million down and up to
VaxGen faces possible liquidation after merger flops
The spectacularly unsuccessful VaxGen has called off an effort to
